Company Profile
Mersana Therapeutics Stock Price, News & Analysis
- Ticker:
- MRSN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for MRSN.
Company overview
Business overview
Mersana Therapeutics is an oncology company developing antibody-drug conjugates for cancer. The company’s identity is built around payload delivery and targeted tumor therapy.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Mersana sits in oncology biotechnology.
Business Model Characteristics
Its business depends on clinical data, platform differentiation, and the ability to turn ADC science into a commercial story.
Position Within the Biotechnology Landscape
Mersana is a classic ADC catalyst name where efficacy and tolerability can quickly change sentiment.
Future catalysts
Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly. The company is still very much a data story.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Mersana Therapeutics do?
Mersana Therapeutics is an oncology company developing antibody-drug conjugates for cancer. The company’s identity is built around payload delivery and targeted tumor therapy.
On which exchange is MRSN stock listed?
Mersana Therapeutics (MRSN) is associated with NASDAQ, United States, Biopharma.
What is XMT-1660?
Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly.
Which conditions is Mersana Therapeutics targeting with XMT-1660?
Mersana Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Mersana Therapeutics describe recent progress with XMT-1660?
Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly.
What is XMT-2056?
Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly.
What should investors watch for with XMT-2056?
Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly.
What is Mersana?
Mersana Therapeutics is an oncology company developing antibody-drug conjugates for cancer.